KHAN , R., MASOOD , A., KHAN , S., MASOOD , A., ABDULMANAN, ., & ZULFIQAR , A. (2024). DOCETAXEL VERSUS DOCETAXEL PLUS CAPECITABINE AS NEOADJUVANT CHEMOTHERAPY FOR TRIPLE-NEGATIVE BREAST CANCER PATIENTS. Biological and Clinical Sciences Research Journal, 2024(1), 654. https://doi.org/10.54112/bcsrj.v2024i1.654